CX3CL1 and neurodegenerative disease: Studies in the CNS have shown that fractalkine signaling exert neuroprotective actions in many neuroinflammatory and neurodegenerative disease models and can also prevent neuronal damage during glutamate excitotoxity (Cardona et al., 2006; Limatola and Ransohoff, 2014).